• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Menarini Group - Product Pipeline Review - Q2 2011 Product Image

Menarini Group - Product Pipeline Review - Q2 2011

  • Published: July 2011
  • 44 pages
  • Global Markets Direct

Menarini Group – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Menarini Group - Product Pipeline Review - Q2 2011” provides data on the Menarini Group’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Menarini Group’s corporate website, SEC filings, investor presentations and featured press releases, both from Menarini Group and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Menarini Group - Brief Menarini Group overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Menarini Group human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment READ MORE >



List of Tables
List of Figures
Menarini Group Snapshot
Menarini Group Overview
Key Information
Key Facts
Menarini Group – Research and Development Overview
Key Therapeutic Areas
Menarini Group – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Menarini Group – Pipeline Products Glance
Menarini Group Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Menarini Group – Drug Profiles
Amediplase
Product Description
Mechanism of Action
R&D Progress
Brivudin
Product Description
Mechanism of Action
R&D Progress
Ibodutant
Product Description
Mechanism of Action
R&D Progress
MEN16132
Product Description
Mechanism of Action
R&D Progress
Nepadutant
Product Description
Mechanism of Action
R&D Progress
Sabarubicin
Product Description
Mechanism of Action
R&D Progress
Sabarubicin + cisplatin
Product Description
Mechanism of Action
R&D Progress
Brivudin
Product Description
Mechanism of Action
R&D Progress
Menarini Group – Pipeline Analysis
Menarini Group – Pipeline Products by Therapeutic Class
Menarini Group - Pipeline Products By Target
Menarini Group – Pipeline Products by Route of Administration
Menarini Group – Pipeline Products by Molecule Type
Menarini Group – Recent Pipeline Updates
Menarini Group – Company Statement
Menarini Group – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Menarini Group, Deals Volume Summary, 2004 to YTD 2011
Menarini Group, Deals Summary By Region, 2004 to YTD 2011
Menarini Group, Deals Summary, 2004 to YTD 2011
Menarini Group Detailed Deal Summary
Asset Purchase
PLIVA Sells AWD Manufacturing Plant In Germany
Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics
Nanogen Enters Into An Agreement With A. Menarini Diagnostics
Spectral Diagnostics Enters Into Distribution Agreement With Menarini
ALK-Abello Enters Into An Agreement With Menarini
Licensing Agreements
Menarini Enters Into Licensing Agreement With Ipsen
CV Therapeutics Enters Into An Licensing Agreement With Menarini Group
Recordati Enters Into Licensing Agreement With The Menarini Group
The Menarini Group Enters Into License Agreement With Faes Farma
Oscient Pharmaceuticals Enters Into License Agreement With Menarini Group For FACTIVE
The Menarini Group Terminates License Agreement With Solagran
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Menarini Group – Pipeline by Therapy Area and Indication, 2011
Menarini Group – Pipeline by Stage of Development, 2011
Menarini Group – Monotherapy Products in Pipeline, 2011
Menarini Group – Combination Treatment Modalities in Pipeline, 2011
Menarini Group - Phase II, 2011
Menarini Group - Phase I, 2011
Menarini Group - Pipeline By Therapeutic Class, 2011
Menarini Group - Pipeline By Target, 2011
Menarini Group – Pipeline By Route of Administration, 2011
Menarini Group – Pipeline By Molecule Type, 2011
Menarini Group – Recent Pipeline Updates, 2011
Menarini Group, Other Locations
Menarini Group, Subsidiaries
Menarini Group, Deals Summary, 2004 to YTD 2011
Menarini Group, Deals Summary by Region, 2004 to YTD 2011
Menarini Group, Deals Summary, 2004 to YTD 2011

List of Figures
Menarini Group – Pipeline by Therapy Area and Indication, 2011
Menarini Group – Pipeline by Stage of Development, 2011
Menarini Group – Monotherapy Products in Pipeline, 2011
Menarini Group – Combination Treatment Modalities in Pipeline, 2011
Menarini Group – Pipeline By Therapeutic Class, 2011
Menarini Group - Pipeline By Target, 2011
Menarini Group – Pipeline By Route of Administration, 2011
Menarini Group – Pipeline By Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos